Introduction
Bovine respiratory syncytial virus (BRSV) is a major cause of respiratory disease in calves resulting in substantial economic losses (Bohlender et al., 1982 ; Collins et al., 1988 ; Paccaud & Jacquier, 1970 ; Stott & Taylor, 1985) . BRSV is an enveloped, single-stranded negative-sense RNA virus in the genus Pneumovirus of the family Paramyxoviridae, which also includes human respiratory syncytial virus (HRSV), pneumonia virus of mice (PVM), and turkey rhinotracheitis virus [now called avian pneumovirus (APV)]. BRSV and HRSV have similar gene and protein composition, but there are differences in host range between the two viruses and the major protective antigens are too distinct antigenically to provide crossprotection. In general, HRSV grows better in primate cells and BRSV grows more efficiently in bovine cells (Matumoto et al., 1974 ; Paccaud & Jacquier, 1970) .
The BRSV genome, like that of HRSV, encodes ten mRNAs (Lerch et al., 1989) . The nucleotide and deduced amino acid sequences of nine mRNAs of BRSV and the intergenic sequences of all the genes of BRSV have been determined Zamora & Samal, 1992 a, b ; Mallipeddi & Samal, 1992 ; Pastey & Samal, 1995 ; Walravens et al., 1990 ; Lerch et al., 1990) . Comparison of the deduced amino acid sequences of these BRSV proteins to those of their counterparts in HRSV subgroup A showed the following percentage identities : nonstructural protein 1 (NS1), 69 % ; nonstructural protein 2 (NS2), 84 % ; nucleocapsid protein (N) 93 % ; phosphoprotein (P), 81 % ; matrix protein (M), 89 % ; small hydrophobic protein (SH), 38 % ; glycoprotein (G), 30 % ; fusion protein (F), 81 % ; and M2 protein, 80 %. In this report, we describe the nucleotide and the deduced amino acid sequences of the remaining BRSV large polymerase (L) gene and compare them with other available pneumoviral L proteins of HRSV and APV. Furthermore, we describe the development of a BRSV minigenome system and demonstrate the functionality of the L cDNA clone using this system.
Methods
Cloning and sequencing of the L gene. The A51908 strain of BRSV, originally isolated in Maryland, USA (Mohanty et al., 1975) , and available in the ATCC (VR-794), was used in this study. Total RNA was isolated from BRSV-infected bovine kidney (MDBK) cells by the guanidinium thiocyanate-CsCl procedure (Chirgwin et al., 1979) . Poly(A) + RNA was purified using an oligo(dT)-cellulose column (Aviv & Leder, 1972) . The GeneTrapper positive selection system (Life Technologies) was used to enrich BRSV L gene cDNA clones. A positive-sense BRSV L gene-start primer, 5h ATGGATACACTCATTCATGAGAA-CTCAAC 3h, made from the BRSV M2-L gene overlap region (Zamora & Samal, 1992 b) was used to trap BRSV L gene cDNAs. Cloning and transformation procedures were as specified by the manufacturer (Life Technologies). Clones containing the L mRNA nucleotide sequences were identified by hybridization with a nucleic acid probe made from the HRSV L gene . However, analysis of BRSV L gene cDNA clones showed large deletions of 3h end nucleotides. A 3n8 kb clone (LA) corresponding to the 5h-half of BRSV L mRNA was obtained using the GeneTrapper positive selection system. The LA clone was sequenced by the dideoxynucleotide chain-termination method and by the automated DNA sequencing method. Repeated attempts to prepare full-length L cDNA clones directly from poly(A)-selected mRNAs were unsuccessful.
A cDNA clone (LB) representing the 3h end of BRSV L mRNA was obtained by RT-PCR of genomic RNA. The genomic RNA was isolated from partially purified BRSV. Briefly, supernatants from BRSV-infected cells were diluted to 8 % with respect to PEG 6000 and incubated for 3 h at 4 mC. Virus was pelleted by centrifugation at 3000 g for 30 min at 4 mC. The virus pellet was resuspended in PBS and stored at 4 mC. The genomic RNA was extracted using TRIzol reagent (Life Technologies) according to the supplier's protocol except that the RNAs were extracted once with phenol-chloroform following isopropanol precipitation. cDNA was synthesized by reverse transcription of genomic RNA using SuperScript II reverse transcriptase (Life Technologies) with a positive-sense L46 primer 5h CACCACTAGCACTATAACTAGTGGT 3h made from the sequence of clone LA. The RT reaction mix was treated with 2 U RNase H for 20 min at 37 mC before PCR. Five microlitres of the RT reaction mix was used in a 50 µl PCR. The PCR primers comprised the same positivesense primer used in the RT reaction together with a negative-sense L44 primer, 5h ACGAGAAAAAAAGTGTCAAAAACTA 3h, from the trailer sequence of HRSV (Mink et al., 1991) . A high-fidelity LA Taq polymerase (Panvera) was used in the PCR. Amplifications were performed with 1 cycle of denaturation at 95 mC for 4 min followed by 30 cycles of denaturation at 95 mC for 1 min, annealing at 60 mC for 1 min and extension at 72 mC for 3 min. The PCR product was cloned into a TA cloning vector (Invitrogen). The LB clone, which contained the 3h end 3000 nt of the L gene was sequenced by the dideoxynucleotide chaintermination and automated DNA sequencing methods.
Clones LA and LB shared a 100 nt overlapping sequence ; therefore, the complete nucleotide sequence of the BRSV L gene could be obtained from these two clones. However, the overlap did not contain a convenient site for joining the cDNAs. Analysis of the nucleotide sequence of the BRSV L gene identified two unique restriction enzyme sites, a PstI site at position 1095 and a BamHI site at position 5545. Using these data, three separate RT-PCRs were carried out with genomic RNA to amplify the entire L gene in three separate fragments, a 5h end 1095 nt NcoI-PstI fragment, a 4550 nt PstI-BamHI middle fragment and a 3h end 1050 nt BamHI-XhoI fragment. A full-length BRSV L gene cDNA was generated by cloning the above three fragments successively 5h to 3h in the modified multiple cloning site of plasmid pTM-1 (NcoI\PstI\BamHI\XhoI). In pTM-1, the L cDNA is under the control of the promoter for T7 RNA polymerase and is preceded by the internal ribosome entry site of encephalomyocarditis virus, so that the ATG of this entry site (contained within the NcoI site 5h CCATGG) serves as the ATG for BRSV cDNA (Elroy-Stein et al., 1989) . The L gene cDNA clone L-3 was entirely sequenced by the automated DNA sequencing method and the sequence obtained was identical to the assembled clone LA and LB sequences. The nucleotide and the deduced amino acid sequence data were assembled, analysed and compared with the published L gene nucleotide sequences of HRSV and APV using the AssemblyLign and MacVector 5.0 programs (Oxford Molecular Group).
Construction of BRSV minigenome cDNA. The functionality of the L gene cDNA clone was determined by monitoring the transcription and replication of a plasmid-based BRSV minigenome system similar to the one described for HRSV (Grosfeld et al., 1995) and measles virus minireplicon (Sidhu et al., 1995) . A BRSV minigenome was constructed in which all of the viral protein coding sequences that lie between the genomic termini and the putative transcription motifs (the start of NS1 gene and the end of L gene) were removed and replaced with a negativesense copy of the bacterial chloramphenicol acetyltransferase (CAT) gene (Fig. 2 A) . Briefly, in the BRSV minigenome, the CAT gene is flanked by a BRSV 3h leader region (45 nt), the NS1 gene-start (CCCCGUUUA) with its noncoding sequence (34 nt), and the L gene untranslated region (17 nt) with the L gene-end signal (UCAAUAAAUUUUU) contiguous with the BRSV trailer (162 nt) sequence at the 5h end. An 84 nt hepatitis delta virus (HDV) ribozyme sequence (Perotta & Been, 1991) carrying a natural RsrII site was fused to the 3h leader end and, abutting the trailer, a T7 promoter sequence with a SmaI site at its 5h end was added to the 3h Leader-CAT-Trailer 5h construct by PCR using synthetic oligonucleotides. The resulting PCR product was double-digested with RsrII and SmaI restriction enzymes and cloned into the RsrII-SmaI window of a W-2 plasmid (a gift from Peter Collins, NIH, Bethesda, MD, USA) which carried the remaining sequence of delta (δ) ribozyme and the T7 transcription terminator (Tφ) sequences to give the BLT δ7 construct (Fig.  2 B) . The sequence of BLT δ7 was confirmed in its entirety. Transcription from the T7 promoter would yield a 955 nt negative-sense transcript, including the three G residues from the T7 promoter, and an exact 3h terminus at the end of the leader sequence would be generated intracellularly by self-cleavage executed by the HDV ribozyme sequence (Fig. 2 C) .
Virus infections and cDNA transfections. cDNAs containing the ORFs of BRSV N, P and M2 proteins were placed under the control of the T7 promoter into the NcoI-BamHI window of plasmid pTM-1. Transfection and infection with vaccinia virus vTF7-3 were performed as described by Grosfeld et al. (1995) . Confluent monolayers of Hep2 cells in 6-well plates were used in the transfection experiment. Each well was infected with 10 p.f.u. per cell of vaccinia virus vTF7-3 expressing T7 RNA polymerase and transfected 45 min later with either N, N\P, N\P\M2, N\P\M2\L3 or N\P\L3 with BLT δ7, respectively, or with BLT δ7 plasmid alone. Amounts of plasmids used were 0n4 µg BLT δ7, 0n4 µg N, 0n2 µg P, 0n1 µg L and 0n05 µg M2. In addition, two wells were infected simultaneously with HRSV\vTF7-3 or BRSV\vTF7-3 and transfected with 0n4 µg BLT δ7 alone, in order to ascertain whether HRSV CAT assay and Northern blot. Cells were harvested at 36 h postinfection and 1\20 of the cell volume was processed for the CAT assay (Gorman et al., 1982) . The remaining cell suspension was used for total RNA extraction and Northern hybridization according to Grosfeld et al. (1995) . Briefly, the total intracellular RNA was extracted with TRIzol reagent according to the supplier's protocol. One-fifth of the total RNA extracted (approximately 15 µg) was electrophoresed on 0n44 M formaldehyde, 1n5 % agarose gel and transferred to 0n2 µm nitrocellulose membrane. The RNAs were fixed by UV cross-linking (Stratagene). Prehybridization was performed for 6 h at 65 mC with prehyb\hyb buffer (Quality Biological) containing 6i SSC, 5i Denhardt's solution, 0n5% SDS and 0n5 mg\ml sheared salmon sperm DNA. Hybridization was performed overnight under the same conditions with approximately 2i10' d.p.m. of a positive-sense strand-specific RNA probe made by in vitro transcription of CAT cDNA.
Results and Discussion
The complete sequence of the BRSV L gene comprises 6573 nt. The BRSV L gene initiates with a gene-start signal (5h GGACAAAAU, mRNA-sense) within the upstream M2 gene. As described earlier (Zamora & Samal, 1992 b) , there is a 67 nt overlap between the M2 and L gene which is very similar to the 68 nt M2-L gene overlap observed in HRSV (Collins et al., 1987) . The gene-end signal of the BRSV M2 gene (3h UCAAUAAAUUUU 5h, vRNA-sense) is located within the L gene (position 52-67) and serves as a part of the ORF that encodes the L protein. The first methionine codon (nucleotides 8-10 relative to the 5h G of the gene-start signal) in the L gene sequence is located in a highly favourable context (5h AAAAUGG) for initiation of eukaryotic translation by having an A residue in the k3 position and a G residue at the j4 position (italicized) (Kozak, 1987) . This start codon initiates a single large ORF of 2162 aa which is 3 aa shorter than HRSV (nt 8-6494 of the complete mRNA sequence). An untranslated region of 77 nt is located at the 3h end (not including the single termination codon, but including the gene-end signal). Nucleotide sequence alignment of the BRSV L gene with that of the HRSV L gene and the APV L gene revealed overall identities of 77n1 and 50n4 %, respectively. Nucleotide sequence alignment of the APV L gene with the HRSV L gene revealed a slightly higher identity of 54n4%.
The deduced amino acid sequence of BRSV L protein has a calculated molecular mass of 249 261 Da, a high isoleucine and leucine content (21n87 % combined) which is almost identical to that of the HRSV L protein (21n9 %), and an overall net charge of j70 at neutral pH, which lies between the calculated overall net charges of j75 for the HRSV L protein and j64 for the APV L protein (Randhawa et al., 1996) . Alignment of the amino acid sequence of BRSV L protein with the sequences of HRSV L and APV L proteins revealed identities of 83n8 and 64n3 %, respectively. As expected from the nucleotide sequence alignment data, the APV L protein shares a slightly greater amino acid identity (65n7 %) with the HRSV L protein.
The M2-L gene overlap in BRSV is 1 nt shorter than the 68 nt overlap observed in HRSV. This 1 nt difference results from the fact that the BRSV gene-start signal (5h GGAC-AAAAU 3h, mRNA-sense) is 1 nt shorter than the HRSV genestart signal (5h GGGACAAAAU) because of the lack of a single 5h-terminal G residue (Fig. 3) . The L protein of BRSV initiates within its upstream neighbour M2 gene. Like the HRSV L protein, the BRSV L protein contains an aminoterminal extension of 70 aa and a carboxy-terminal truncation of up to 100 aa. BRSV and HRSV L proteins share an identity of 80 % in their amino-terminal 70 aa. About 50 % of the 14 non-identical amino acids represent exchanges with conserved residues.
All the amino acid motifs identified by Stec et al. (1991) in the HRSV L protein were perfectly conserved in the BRSV L protein (Fig. 1) . However, APV L protein differs by 1-4 aa from both the BRSV and HRSV L proteins in all the four core polymerase motifs [A, B, C and D of domain III (boxed in Fig.  1) ]. Like HRSV and APV, most of the six blocks of strong conservation, I-VI identified by Poch et al. (1989 Poch et al. ( , 1990 , were also present in the BRSV L protein. The invariant tripeptide GHP in block I, the KERE (hydrophobic) motif of block II and the tetrapeptide GDNQ in block III are also a feature of BRSV L protein. A putative ATP-binding site K(X) #" GEGAGN(X) #! K ( Kamps et al., 1984) identified in domain VI of the BRSV L protein is identical to that found in the L proteins of HRSV and APV (Randhawa et al. 1996) .
The result of the CAT assay (Fig. 3) showed that minigenome transcription occurred in the presence of N, P and L proteins (lane 5), N, P, M2 and L proteins (lane 4) or when these proteins were supplied by either HRSV (lane 6) or BRSV (lane 7). Furthermore, no transcription of the minigenome occurred, as indicated by a lack of CAT activity, when the L protein was omitted from transfection ( Fig. 3 A, C, lane 3) . Northern blot results indicated that BRSV-CAT RNA was replication-competent only in the presence of either HRSV (lane 6) or BRSV (lane 7) or when N, P and L proteins were supplied from cDNAs (lanes 4 and 5). However, in the Northern blot, the positive-sense CAT riboprobe also hybridized to a slow-migrating RNA band (Fig. 3 B, UC) especially in lanes 4-7, which probably represents a fraction of T7 primary transcript derived from vTF7-3-driven transcription of BLT δ7 that remained uncleaved at its HDV ribozyme site. Similar observations were also made by Wertz et al. (1994) who worked with a vesicular stomatitis virus genome analogue and reported suboptimal cleavage at the HDV ribozyme sequence. Since the TRIzol protocol separates RNA from DNA, our total RNAs were not treated with DNase prior to Northern blot hybridization.
Our results showed that the BRSV L protein together with BRSV N and P proteins directed transcription and replication of the BRSV-CAT minigenome RNA confirming that N, P and L proteins are the minimum trans-acting proteins that are necessary and sufficient for BRSV minigenome rescue (Fig. 3 A,  B) , which is identical to results obtained by Yu et al. (1995) and Grosfeld et al. (1995) with HRSV vRNA analogues. This assay confirmed that the L gene cDNA clone encoded a functional protein. The inclusion of the M2 gene along with the N, P and L plasmids augmented minigenome rescue, as evident by the markedly improved acetylation in the CAT assay (Fig. 3 A, lane 4) and increased amounts of negative-sense vRNA analogue that were detected in the Northern analysis (Fig. 3 B,  lane 4) . This effect agrees with the observation of Collins et al. (1996) who found that inclusion of the M2 gene at low molar levels relative to the N protein (N : M2 ratio of 1 : 0n04) resulted in the efficient production of full-length mRNA and did not inhibit RNA replication. Furthermore, as expected, superinfection with HRSV provided all the trans-acting proteins required for BRSV minigenome rescue. Surprisingly, the efficiency of rescue observed with HRSV (Fig. 3, lane 6 ) was remarkably better than that observed with homologous BRSV superinfection (Fig. 3, lane 7) , as seen from improved CAT activity and a larger quantity of vRNA analogue observed in the Northern blot. This could be due to the higher m.o.i. of HRSV (10 p.f.u.) used in the superinfection when compared to the lower m.o.i. of 2 p.f.u. used in case of BRSV (BRSV does not grow to high titres). Nevertheless, this result shows that HRSV proteins are able to recognize BRSV cis-acting elements and participate in transcription and replication of the BRSV minigenome. The BRSV-CAT RNA that was efficiently rescued was 955 nt long, which is not a multiple of six. This indicates that BRSV, like HRSV (Samal & Collins, 1996) and APV (Randhawa et al., 1997) probably does not obey the rule of six (Calain & Roux, 1993) .
Sequence analysis and comparison of the BRSV L protein with the other two pneumoviral L proteins showed that BRSV and HRSV are more closely related to each other than either is to APV. Furthermore, our results show that HRSV proteins recognize BRSV cis-acting elements much more efficiently than was observed for the APV-CAT RNA analogue by Randhawa Sequence analysis of BRSV polymerase gene Sequence analysis of BRSV polymerase gene (1997) , who reported that the amount of CAT protein was never more than 3 % of the amount observed with homologous virus. In fact, the high percentage of homology observed in other BRSV genes, the M2-L gene overlap, the identical gene order in the viral genomic organization and, lastly, the identical\invariant motifs observed in the BRSV L gene along with a high overall protein identity suggest a close evolutionary relationship between BRSV and HRSV. However, the derivation of an exact phylogenetic tree within the genus Pneumovirus must await the availability of the L gene sequence of PVM.
The availability of a functional cDNA clone of the BRSV L protein and development of a helper virus-free rescue system would enable recovery of infectious BRSV entirely from cloned cDNA. Although BRSV and HRSV show a high degree of sequence identity, BRSV grows more poorly than HRSV (i.e. to at least a 10-fold lower titre than HRSV). Hence, whether or not the poor growth observed in BRSV can be attributed to individual genes such as L needs to be further investigated. The development of a reconstituted cDNA-expressed BRSV minigenome system and establishment of the minimal trans-acting protein requirements would enable further characterization of these proteins and the cis-acting elements. Any possible attenuating effect identified with the minigenome system has a potential application in the development of live recombinant BRSV vaccines.
